Book contents
- The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
- The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
- Copyright page
- Dedication
- Contents
- Videos
- Contributors
- Preface
- Section 1 Basic Sciences in Gynaecology
- Section 2 Menstrual Disorders
- Chapter 6 Paediatric and Adolescent Gynaecology
- Chapter 7 Heavy Menstrual Bleeding
- Chapter 8 Management of Uterine Fibroids
- Chapter 9 Early-Onset Endometriosis
- Chapter 10 Chronic Pelvic Pain
- Section 3 Reproductive Endocrinology and Infertility
- Section 4 Contraception and STIs
- Section 5 Post-Reproductive Care
- Section 6 Vulva and Vagina
- Section 7 Cervix
- Section 8 Uterus
- Section 9 Ovary and Fallopian Tubes
- Section 10 Operative Gynaecology
- Section 11 Public Health Issues in Gynaecology
- Section 12 Miscellaneous
- Index
- Plate Section (PDF Only)
- References
Chapter 8 - Management of Uterine Fibroids
from Section 2 - Menstrual Disorders
Published online by Cambridge University Press: 24 November 2021
Book contents
- The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
- The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
- Copyright page
- Dedication
- Contents
- Videos
- Contributors
- Preface
- Section 1 Basic Sciences in Gynaecology
- Section 2 Menstrual Disorders
- Chapter 6 Paediatric and Adolescent Gynaecology
- Chapter 7 Heavy Menstrual Bleeding
- Chapter 8 Management of Uterine Fibroids
- Chapter 9 Early-Onset Endometriosis
- Chapter 10 Chronic Pelvic Pain
- Section 3 Reproductive Endocrinology and Infertility
- Section 4 Contraception and STIs
- Section 5 Post-Reproductive Care
- Section 6 Vulva and Vagina
- Section 7 Cervix
- Section 8 Uterus
- Section 9 Ovary and Fallopian Tubes
- Section 10 Operative Gynaecology
- Section 11 Public Health Issues in Gynaecology
- Section 12 Miscellaneous
- Index
- Plate Section (PDF Only)
- References
Summary
With a lifetime prevalence of up to 75%, uterine fibroids are the most common benign tumour of the female reproductive system. Fibroids present the most common indication for hysterectomy and are associated with high health-related costs. They can severely affect the quality of life of these women and may diminish fertility. This chapter provides an overview of the aetiology, prevalence, diagnosis and treatment options for uterine fibroids. As the reproductive phase is shifting ever further back into the life of a woman, conservative therapy options are becoming increasingly important.
- Type
- Chapter
- Information
- The EBCOG Postgraduate Textbook of Obstetrics & GynaecologyGynaecology, pp. 65 - 71Publisher: Cambridge University PressPrint publication year: 2021
References
Foth, D, Röhl, F-W, Friedrich, C. Symptoms of uterine myomas: data of an epidemiological study in Germany. Arch Gynecol Obstet 2017;295:415–426.Google Scholar
Ahrendt, HJ, Tylkoski, H, Rabe, T. Prevalence of uterine myomas in women in Germany: data of an epidemiological study. Arch Gynecol Obstet 2016;293:1243–1253.CrossRefGoogle ScholarPubMed
Huyck, KL, Panhuysen, CIM, Cuenco, KT. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol 2008;198:168 e1–168 e9.CrossRefGoogle ScholarPubMed
Pavone, D, Clemenza, S, Sorbi, F, et al. Epidemiology and risk factors of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2018;46:3–11.Google Scholar
Parker, WH. The utility of MRI for the surgical treatment of women with uterine fibroid tumors. Am J Obstet Gynecol 2012;206:31–36.Google Scholar
Munro, MG, Critchley, HOD, Broder, MS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113:3–13.Google Scholar
Dubuisson, J. The current place of mini-invasive surgery in uterine leiomyoma management. J Gynecol Obstet Hum Reprod 2019;48:77–81.Google Scholar
Bryant-Smith, AC, Lethaby, A, Farquhar, C, Hickey, M. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2018;4:CD000249.Google Scholar
Qin, J, Yang, T, Kong, F, Zhou, Q. Oral contraceptive use and uterine leiomyoma risk: a meta-analysis based on cohort and case-control studies. Arch Gynecol Obstet 2013;288:139–148.Google Scholar
Schreiber, CA, Teal, SB, Blumenthal, PD, Keder, LM, et al. Bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system. Eur J Contracept Reprod Health Care 2018;23:116–120.Google Scholar
Römer, TDK, Foth, D, Hadji, P, et al. Symptomatischer Uterus myomatosus. Zielgerichtete medikamentöse Therapie Frauenarzt 2017;6:497–503.Google Scholar
Ali, M, Al-Hendy, A. Uterine fibroid therapy: the pharmacokinetic considerations. Expert Opin Drug Metab Toxicol 2018;14:887–889.Google Scholar
Sinai Talaulikar, V. Medical therapy for fibroids: an overview. Best Pract Res Clin Obstet Gynaecol 2018;46:48–56.CrossRefGoogle ScholarPubMed
Singh, SS, Belland, L. Contemporary management of uterine fibroids: focus on emerging medical treatments. Curr Med Res Opin 2015;31:1–12.CrossRefGoogle ScholarPubMed
Kamath, MS, Kalampokas, EE, Kalampokas, TE. Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2014;177:11–18.Google Scholar
Donnez, J, Tomaszewski, J, Vázquez, F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012;366:421–432.CrossRefGoogle ScholarPubMed
Donnez, J, Vázquez, F, Tomaszewski, J, et al. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril 2014;101:1565–73 e1–18.CrossRefGoogle ScholarPubMed
Rabe, T, Sanger, N, Ebert, AD, et al. Die Anwendung von Selektiven Progesteron-rezeptor-modulatoren (SPrms) zur medikamentösen behandlung von uterusmyomen: ulipristalacetat im Fokus. J Reproduktionsmed Endokrinol_Online 2017;14:113–122.Google Scholar
Donnez, J, Donnez, O, Matule, D, et al. Long-term medical management of uterine fibroids with ulipristal acetate. Fertil Steril 2016;105:165–173 e4.CrossRefGoogle ScholarPubMed
Donnez, J. Liver injury and ulipristal acetate: an overstated tragedy? Fertil Steril 2018;110:593–595.CrossRefGoogle ScholarPubMed
Kriplani, A, Srivastava, A, Kulshrestha, V, et al. Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma. J Obstet Gynaecol Res 2016;42:1744–1752.Google Scholar
Fauser, BC, Donnez, J, Bouchard, P, et al. Safety after extended repeated use of ulipristal acetate for uterine fibroids. PLoS One 2017;12:e0173523.CrossRefGoogle ScholarPubMed
AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL position statement: route of hysterectomy to treat benign uterine disease. J Minim Invasive Gynecol 2011;18:1–3.Google Scholar
Miskry, T, Magos, A. Randomized, prospective, double-blind comparison of abdominal and vaginal hysterectomy in women without uterovaginal prolapse. Acta Obstet Gynecol Scand 2003;82:351–358.Google Scholar
Andres, MP, Borrelli, GM, Abrao, MS. Advances on minimally invasive approach for benign total hysterectomy: a systematic review. F1000Res 2017;6:1295.CrossRefGoogle ScholarPubMed
Taylan, E, Sahin, C, Zeybek, B, Akdemir, A. Contained morcellation: review of current methods and future directions. Front Surg 2017;4:15.CrossRefGoogle ScholarPubMed
Sesti, F, Ruggeri, V, Pietropolli, A, Piccione, E. Laparoscopically assisted vaginal hysterectomy versus vaginal hysterectomy for enlarged uterus. JSLS 2008;12:246–251.Google Scholar
Cezar, C, Becker, S, di Spiezio Sardo, A. Laparoscopy or laparotomy as the way of entrance in myoma enucleation. Arch Gynecol Obstet 2017;296:709–720.CrossRefGoogle ScholarPubMed
Young, M, Mikhail, LN. Uterine Fibroid Embolization. Treasure Island (FL): StatPearls, 2018.Google Scholar
Sridhar, D, Kohi, MP. Updates on MR-guided focused ultrasound for symptomatic uterine fibroids. Semin Intervent Radiol 2018;35:17–22.Google Scholar